| Literature DB >> 35768115 |
Weijie Li1, Jialin He1, Jun Fan1, Jiankai Huang1, Pingan Chen1, Yizhi Pan2.
Abstract
OBJECTIVE: Intracoronary ECG (IC-ECG) recording has been shown to be sensitive and reliable for detecting myocardial viability and local myocardial ischaemia in some studies. But IC-ECG is neither widely used during percutaneous coronary intervention (PCI) nor recommended in guidelines. This up-to-date meta-analysis of published studies was conducted to evaluate the prognostic and diagnostic accuracy of IC-ECG recorded during PCI.Entities:
Keywords: cardiology; coronary heart disease; coronary intervention
Mesh:
Year: 2022 PMID: 35768115 PMCID: PMC9244681 DOI: 10.1136/bmjopen-2021-055871
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 3.006
Figure 1Selection of included studies. IC-ECG, intracoronary ECG; RR, risk ratio.
The characteristics of included studies
| Studies | Study design | No of cases | Male (%) | Age (years old) | Follow-up (months) | Reference standards |
| Ikenaga | Cohort study, single centre | 84 | 36.8 | 67.4±9.9 | 12 | N/A |
| Wong | Cohort study, single centre | 64 | 82.8 | 61.0±10.0 | 3 | N/A |
| Hishikari | Cohort study, single centre | 111 | 73.9 | 68.8±12.6 | 35* | N/A |
| Uetani | Cohort study, single centre | 339 | 66.4 | 69.7±8.6 | In hospital | N/A |
| Balian | Cohort study, single centre | 50 | 84.0 | 59.3±11.0 | 6 | N/A |
| Yajima | Cohort study, single centre | 65 | 75.4 | 61.3±7.0 | 1 | N/A |
| Balian | Cohort study and diagnostic study, single centre | 108 | 87.3 | 61.7±10.0 | 12±5 | Troponin I |
| Balian | Diagnostic study | 48 | 52.0 | 65.0±9.0 | N/A | FFR |
| Abaci | Diagnostic study | 71 | 84.5 | 54.0±11.0 | N/A | Low-dose dobutamine echocardiography |
| FIESTA. 2018, Bulgaria | Diagnostic study | 37 | 69.0 | 65.0±10.0 | N/A | FFR |
| Wang | Diagnostic study | 86 | 67.4 | 54.5±10.2 | N/A | Troponin T |
| Vassilev | Diagnostic study | 135 | 59.2 | 65.1±10.0 | N/A | Troponin I |
*The median followed-up period of this study was 35 months (28–40 months).
FFR, fractional flow reserve; N/A, not available.
Figure 2The correlation between ST-segment elevation recorded by IC-ECG and clinical outcomes. The clinical outcomes were (A) MACE, (B) cardiac death, (C) myocardial infarction, and (D) revascularisation, respectively. We pooled ORs using a random-effects meta-analysis method. ST-segment elevation recorded by IC-ECG after PCI procedures was significantly associated with higher risk of MACE and myocardial infarction during follow-up, but was not significantly associated with cardiac death nor revascularisation. IC-ECG, intracoronary ECG; mace, major adverse cardiac event.
Figure 3The differences in ejection fraction (EF) between different results recorded by IC-ECG during follow-up. We pooled unstandardised mean difference using a random-effects meta-analysis method. EF was significantly higher during follow-up when ST-segment resolution was observed on IC-ECG, while we could not find similar result when ST-segment elevation was recorded. IC-ECG, intracoronary ECG; WMD, weighted mean difference.
Figure 4The Bayesian SROC curve of ST-segment elevation recorded by IC-ECG and the posterior distribution of AUC. Each circle identifies the true positive rate versus the false positive rate of each study. The AUC was 0.65 (95% credibility intervals 0.56–0.69). AUC, areas under the curve; FPR, false positive rate; IC-ECG, IC-ECG, intracoronary ECG; SROC, summary receiver-operating-characteristic; TPR, true positive rate.